Logo image of CG

CARLYLE GROUP INC/THE (CG) Stock Fundamental Analysis

USA - NASDAQ:CG - US14316J1088 - Common Stock

63.69 USD
-0.31 (-0.48%)
Last: 9/25/2025, 3:03:06 PM
Fundamental Rating

4

Taking everything into account, CG scores 4 out of 10 in our fundamental rating. CG was compared to 236 industry peers in the Capital Markets industry. While CG is still in line with the averages on profitability rating, there are concerns on its financial health. CG is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CG had positive earnings in the past year.
CG had a negative operating cash flow in the past year.
Of the past 5 years CG 4 years were profitable.
In multiple years CG reported negative operating cash flow during the last 5 years.
CG Yearly Net Income VS EBIT VS OCF VS FCFCG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B

1.2 Ratios

CG has a Return On Assets of 5.01%. This is in the better half of the industry: CG outperforms 69.07% of its industry peers.
Looking at the Return On Equity, with a value of 21.44%, CG belongs to the top of the industry, outperforming 88.56% of the companies in the same industry.
CG has a better Return On Invested Capital (6.80%) than 74.15% of its industry peers.
Industry RankSector Rank
ROA 5.01%
ROE 21.44%
ROIC 6.8%
ROA(3y)2.42%
ROA(5y)4.7%
ROE(3y)8.72%
ROE(5y)19.09%
ROIC(3y)N/A
ROIC(5y)N/A
CG Yearly ROA, ROE, ROICCG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

With a Profit Margin value of 20.22%, CG perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
In the last couple of years the Profit Margin of CG has grown nicely.
With a Operating Margin value of 25.27%, CG perfoms like the industry average, outperforming 46.19% of the companies in the same industry.
In the last couple of years the Operating Margin of CG has declined.
CG has a Gross Margin of 58.27%. This is in the better half of the industry: CG outperforms 68.64% of its industry peers.
In the last couple of years the Gross Margin of CG has declined.
Industry RankSector Rank
OM 25.27%
PM (TTM) 20.22%
GM 58.27%
OM growth 3Y-18.19%
OM growth 5Y-7.53%
PM growth 3Y-17.81%
PM growth 5Y12.96%
GM growth 3Y-0.37%
GM growth 5Y-5.06%
CG Yearly Profit, Operating, Gross MarginsCG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, CG has less shares outstanding
Compared to 5 years ago, CG has more shares outstanding
Compared to 1 year ago, CG has an improved debt to assets ratio.
CG Yearly Shares OutstandingCG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CG Yearly Total Debt VS Total AssetsCG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CG has an Altman-Z score of 1.09. This is a bad value and indicates that CG is not financially healthy and even has some risk of bankruptcy.
CG has a Altman-Z score of 1.09. This is comparable to the rest of the industry: CG outperforms 56.36% of its industry peers.
A Debt/Equity ratio of 1.71 is on the high side and indicates that CG has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.71, CG is doing worse than 76.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.71
Debt/FCF N/A
Altman-Z 1.09
ROIC/WACCN/A
WACCN/A
CG Yearly LT Debt VS Equity VS FCFCG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 0.40 indicates that CG may have some problems paying its short term obligations.
CG has a Current ratio of 0.40. This is in the lower half of the industry: CG underperforms 77.97% of its industry peers.
CG has a Quick Ratio of 0.40. This is a bad value and indicates that CG is not financially healthy enough and could expect problems in meeting its short term obligations.
CG's Quick ratio of 0.40 is on the low side compared to the rest of the industry. CG is outperformed by 77.97% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
CG Yearly Current Assets VS Current LiabilitesCG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

7

3. Growth

3.1 Past

CG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.36%, which is quite good.
The Earnings Per Share has been growing by 16.58% on average over the past years. This is quite good.
Looking at the last year, CG shows a very strong growth in Revenue. The Revenue has grown by 90.86%.
Measured over the past years, CG shows a quite strong growth in Revenue. The Revenue has been growing by 9.95% on average per year.
EPS 1Y (TTM)11.36%
EPS 3Y-9.94%
EPS 5Y16.58%
EPS Q2Q%16.67%
Revenue 1Y (TTM)90.86%
Revenue growth 3Y-14.83%
Revenue growth 5Y9.95%
Sales Q2Q%24.73%

3.2 Future

CG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.30% yearly.
CG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.59% yearly.
EPS Next Y15.61%
EPS Next 2Y16.79%
EPS Next 3Y14.52%
EPS Next 5Y11.3%
Revenue Next Year14.18%
Revenue Next 2Y16.5%
Revenue Next 3Y13.59%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CG Yearly Revenue VS EstimatesCG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CG Yearly EPS VS EstimatesCG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.25, CG is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of CG is on the same level as its industry peers.
CG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
CG is valuated correctly with a Price/Forward Earnings ratio of 12.76.
CG's Price/Forward Earnings is on the same level as the industry average.
CG's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.80.
Industry RankSector Rank
PE 16.25
Fwd PE 12.76
CG Price Earnings VS Forward Price EarningsCG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

75.85% of the companies in the same industry are more expensive than CG, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.98
CG Per share dataCG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CG's earnings are expected to grow with 14.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.04
PEG (5Y)0.98
EPS Next 2Y16.79%
EPS Next 3Y14.52%

More info and screens

4

5. Dividend

5.1 Amount

CG has a Yearly Dividend Yield of 2.02%.
Compared to an average industry Dividend Yield of 8.21, CG has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, CG has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.02%

5.2 History

The dividend of CG decreases each year by -1.73%.
CG has been paying a dividend for at least 10 years, so it has a reliable track record.
CG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-1.73%
Div Incr Years3
Div Non Decr Years4
CG Yearly Dividends per shareCG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

40.07% of the earnings are spent on dividend by CG. This is a bit on the high side, but may be sustainable.
DP40.07%
EPS Next 2Y16.79%
EPS Next 3Y14.52%
CG Yearly Income VS Free CF VS DividendCG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B
CG Dividend Payout.CG Dividend Payout, showing the Payout Ratio.CG Dividend Payout.PayoutRetained Earnings

More info and screens

CARLYLE GROUP INC/THE

NASDAQ:CG (9/25/2025, 3:03:06 PM)

63.69

-0.31 (-0.48%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners64.12%
Inst Owner Change0.6%
Ins Owners25.32%
Ins Owner Change-2.82%
Market Cap23.04B
Analysts75.38
Price Target69.26 (8.75%)
Short Float %4.78%
Short Ratio5.07
Dividend
Industry RankSector Rank
Dividend Yield 2.02%
Yearly Dividend1.4
Dividend Growth(5Y)-1.73%
DP40.07%
Div Incr Years3
Div Non Decr Years4
Ex-Date08-18 2025-08-18 (0.35)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.18%
Min EPS beat(2)-0.6%
Max EPS beat(2)16.95%
EPS beat(4)2
Avg EPS beat(4)2.66%
Min EPS beat(4)-6.9%
Max EPS beat(4)16.95%
EPS beat(8)5
Avg EPS beat(8)3.9%
EPS beat(12)8
Avg EPS beat(12)6.59%
EPS beat(16)11
Avg EPS beat(16)10.21%
Revenue beat(2)2
Avg Revenue beat(2)4.4%
Min Revenue beat(2)2.98%
Max Revenue beat(2)5.83%
Revenue beat(4)2
Avg Revenue beat(4)-1.37%
Min Revenue beat(4)-9.92%
Max Revenue beat(4)5.83%
Revenue beat(8)3
Avg Revenue beat(8)-2.18%
Revenue beat(12)4
Avg Revenue beat(12)-3.64%
Revenue beat(16)7
Avg Revenue beat(16)7.48%
PT rev (1m)8.9%
PT rev (3m)31.64%
EPS NQ rev (1m)0.45%
EPS NQ rev (3m)3.5%
EPS NY rev (1m)0.3%
EPS NY rev (3m)1.72%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)2.74%
Revenue NY rev (1m)1.67%
Revenue NY rev (3m)4.38%
Valuation
Industry RankSector Rank
PE 16.25
Fwd PE 12.76
P/S 3.71
P/FCF N/A
P/OCF N/A
P/B 3.93
P/tB 4.36
EV/EBITDA 17.98
EPS(TTM)3.92
EY6.15%
EPS(NY)4.99
Fwd EY7.84%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS17.18
BVpS16.2
TBVpS14.62
PEG (NY)1.04
PEG (5Y)0.98
Profitability
Industry RankSector Rank
ROA 5.01%
ROE 21.44%
ROCE 8.68%
ROIC 6.8%
ROICexc 7.52%
ROICexgc 15.04%
OM 25.27%
PM (TTM) 20.22%
GM 58.27%
FCFM N/A
ROA(3y)2.42%
ROA(5y)4.7%
ROE(3y)8.72%
ROE(5y)19.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-39.75%
ROICexcg growth 5Y-2.37%
ROICexc growth 3Y-33.35%
ROICexc growth 5Y-6.78%
OM growth 3Y-18.19%
OM growth 5Y-7.53%
PM growth 3Y-17.81%
PM growth 5Y12.96%
GM growth 3Y-0.37%
GM growth 5Y-5.06%
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 1.71
Debt/FCF N/A
Debt/EBITDA 5.69
Cap/Depr 42.58%
Cap/Sales 1.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z 1.09
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)175.39%
Cap/Depr(5y)144.65%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.36%
EPS 3Y-9.94%
EPS 5Y16.58%
EPS Q2Q%16.67%
EPS Next Y15.61%
EPS Next 2Y16.79%
EPS Next 3Y14.52%
EPS Next 5Y11.3%
Revenue 1Y (TTM)90.86%
Revenue growth 3Y-14.83%
Revenue growth 5Y9.95%
Sales Q2Q%24.73%
Revenue Next Year14.18%
Revenue Next 2Y16.5%
Revenue Next 3Y13.59%
Revenue Next 5YN/A
EBIT growth 1Y426.08%
EBIT growth 3Y-30.32%
EBIT growth 5Y1.66%
EBIT Next Year6.83%
EBIT Next 3Y10.25%
EBIT Next 5Y6.83%
FCF growth 1Y77.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.79%
OCF growth 3YN/A
OCF growth 5YN/A